Altered Response of Progeria Fibroblasts to Epidermal Growth Factor
peer reviewedThe Hutchinson-Gilford syndrome (progeria) is a rare disorder in childhood characterized by premature and accelerated aging. This study reports the effect of a potent growth factor, EGF, on the proliferative capacities and extracellular ...
Lapiere, ChM +2 more
core
Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome. [PDF]
Kang SM +18 more
europepmc +1 more source
Clinical imaging findings in a girl with Hutchinson-Gilford progeria syndrome
[[abstract]]"Clinical imaging findings in a girl with Hutchinson-Gilford progeria syndrome: We report an 8½-year-old girl with premature aging, a karyotype of 46,XX and a de novo c.1824C>T mutation encoding p.G608G in the lamin A gene.
陳持平;Chen, Chih-Ping
core
Extracellular matrix abnormalities in Hutchinson-Gilford progeria fibroblasts: a specific defect in collagen IV and basement membrane architecture? [PDF]
Karmacharya S +15 more
europepmc +1 more source
Artificial intelligence-assisted reinterpretation of preclinical progeria research suggests a hierarchical nuclear-vascular resilience framework with translational implications. [PDF]
Madeddu P, Cattaneo M, Puca AA.
europepmc +1 more source
A toxic STING-SAMHD1 axis drives replication stress in progeria and cancer cells. [PDF]
Teodoro-Castro B +6 more
europepmc +1 more source
Epidural hematoma in a pediatric patient with Hutchinson-Gilford progeria syndrome: management considerations: a case report. [PDF]
Ozmarasali AI, Sivas ZZ, Uguz I, Oto A.
europepmc +1 more source
General anesthesia in patient with Hutchinson-Gilford Progeria syndrome: two case reports of dental treatment in the one patient. [PDF]
Mankovsky B +3 more
europepmc +1 more source
Progeria and hearing loss: parallels and divergences with presbycusis
openLa progeria, patologia rara caratterizzata da invecchiamento precoce, è un settore di ricerca ancora in evoluzione. Il primo gruppo di ricerca strutturato vede la luce solo all’inizio del secolo con la Progeria Research Foundation (PRF). L’obiettivo
VANGELISTA, GIORGIA
core
LAV-BPIFB4 reverses progeria-associated cardiac aging by restoring diastolic function and reducing senescence. [PDF]
Chae U +4 more
europepmc +1 more source

